Acute Myelogenous Leukemia
New acute myelogenous leukemia study findings have been reported from University of British Columbia
Published in Hematology Week, October 15th, 2007
Researchers detail in 'Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia,' new data in acute myelogenous leukemia. "Curative intent chemotherapy for acute myelogenous leukemia (AML) leads to prolonged severe neutropenia, during which patients are highly susceptible to infection. Traditionally these high-risk patients were treated as inpatients," investigators in Vancouver, Canada report.
"Our center recently implemented a selective ambulatory management policy for AML patients undergoing chemotherapy. A retrospective analysis was conducted to assess the occurrence of septicemia in AML patients...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
Source: Hematology Week (2007-10-15)
More Articles from Hematology Week
- Leukemia
Daisies lead scientists down path to new leukemia drug - Vascular Disease
UMass Medical School study identifies the best weight-loss plans for heart health - Biomedicine
New Transfusion Rules Restrict Donations from Previously Pregnant Women - Cord Blood
PerkinElmer to Expand Genetic Screening Business Through Acquisition of ViaCell - Cord Blood
StemCyte, Inc. Ranked Number Six in Deloitte's Technology Fast 50 Program for Los Angeles - Leukemia
Researchers Advancing Blood Cancer Therapies Receive $18.75 Million in Grants from the Society - More from this issue of Hematology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
